In 2000, roughly 25% of the world’s population was myopic. By 2050, the WHO projects that figure will reach 50% — about 5 billion people. Myopia isn’t just a glasses prescription issue; high myopia (over -6.00D) significantly increases the risk of retinal detachment, glaucoma, and macular degeneration later in life. If your child’s prescription is creeping up every year, myopia control treatments exist to slow that progression — but they cost money. Here’s a clear breakdown of what you’ll pay and what the evidence says works.
Why Myopia Control Matters Beyond Glasses
A child who develops myopia at age 7 and gets a new glasses prescription every year without treatment may end up highly myopic by their 20s. Each additional diopter of myopia increases lifetime disease risk. The AOA estimates that reducing final myopia by just 1 diopter can reduce the risk of myopic maculopathy by 40%.
That’s the clinical argument for treatment. The practical parent argument: stopping prescription creep means less frequent glasses changes, smaller lenses, better cosmetics, and eventually better LASIK candidacy as an adult (if desired).
The Main Myopia Control Methods
Low-dose atropine drops (0.01%–0.05%): Nightly eye drops that slow axial eye elongation. The ATOM2 and LAMP studies showed 0.01% atropine reduced myopia progression by about 50–60% compared to untreated controls. One drop per eye, every night.
Orthokeratology (ortho-k) lenses: Rigid contact lenses worn overnight that gently reshape the cornea while sleeping. In the morning, the child has clear daytime vision without glasses or contacts — and axial elongation slows by 40–60% compared to untreated controls per multiple randomized trials.
MiSight 1-day contacts: FDA-approved soft daily contact lenses specifically designed for myopia control in children. The ActivControl technology creates peripheral defocus to reduce axial growth. Three-year clinical data showed 59% reduction in myopia progression compared to standard single-vision contacts.
Stellest and other spectacle lenses: Specialty glasses lenses with defocus patterns embedded. Approved in some markets; gaining traction in the US. Lower commitment than overnight lenses or daily drops.
| Treatment | Upfront Cost | Annual Ongoing Cost | Evidence Level |
|---|---|---|---|
| Low-dose atropine (0.01%) | $50–$100 (initial consult) | $600–$1,800 (compounded) | Strong; multiple RCTs |
| Orthokeratology lenses | $1,500–$2,500 (fitting + lenses) | $300–$600 (follow-up + replacement) | Strong; 40–60% reduction |
| MiSight 1-day contacts | $150–$250 (fitting fee) | $900–$1,400 (daily lens supply) | FDA-approved; 59% reduction |
| Specialty myopia control glasses | $300–$600 (frames + lenses) | $200–$400 (annual replacement) | Moderate; newer evidence |
| Standard single-vision glasses | $150–$400 | $150–$400 | No myopia control effect |
Atropine Drops: The Lowest Cost Option
Low-dose atropine at 0.01% isn’t commercially manufactured in the US at that concentration — it requires compounding pharmacy preparation. Your eye doctor writes a prescription for 0.01% or 0.05% atropine in a preservative-free base; a compounding pharmacy fills it.
Cost ranges widely: $40–$150 per 5–10mL bottle, lasting 1–3 months depending on dosing. Some compounding pharmacies charge a premium; shop around. Olympia Compounding and Leiter’s are commonly used pharmacies. Insurance rarely covers compounded medications, so this is typically an out-of-pocket expense.
The clinical appeal is simplicity: one drop per night, no fitting sessions, no contact lens hygiene protocols for children. Myopia control efficacy is real but somewhat lower than ortho-k or MiSight in head-to-head comparisons.
Ortho-K: High Upfront, Lower Long-Term
Orthokeratology lenses cost $1,500–$2,500 for the full initial treatment package, which typically includes: fitting, corneal topography mapping, trial lens sessions, and the custom-made lenses themselves. Ongoing costs — annual follow-up visits, lens cleaning solutions, replacement lenses every 1–2 years — add $300–$600 per year.
The added benefit: no daytime glasses or contacts. For active kids in sports, this is significant. Many families treat the glasses-free benefit and myopia control as combined value.
Some myopia control specialists combine low-dose atropine with either ortho-k or MiSight for additive effect. Research from the COMET and STAMP studies suggests combination therapy may be more effective than either treatment alone — particularly in children with fast-progressing myopia or early onset (under age 8). If your child is progressing rapidly, ask your provider whether combination therapy is appropriate. Combined ortho-k + atropine can slow progression by 65–75% in some studies. The additional cost of adding atropine to ortho-k is $600–$1,800/year.
Does Insurance Cover Myopia Control?
Rarely. This is one of the most frustrating gaps in vision care coverage.
Orthokeratology: some vision plans (VSP, EyeMed) have ortho-k benefits — check your specific plan. Medical insurance generally doesn’t cover it because it’s classified as elective. Even with coverage, most ortho-k packages cost more than the insurance benefit.
MiSight lenses: covered by the standard contact lens benefit of most vision plans, but the annual lens cost often exceeds the benefit maximum by $400–$800.
Atropine drops: almost never covered by insurance when used for myopia control (they’re being used off-label for a prevention indication, not treating a current medical condition).
FSA/HSA: prescription contact lenses, glasses, and prescription eye drops all qualify. You can use pre-tax dollars to pay for all three types of myopia control treatment.
Myopia control is most effective when started young — ideally before age 10 — and the research evidence is clearest for children aged 6–12. Adult myopia is largely stable, and myopia control treatments aren’t typically recommended for adults whose eyes have stopped growing. If your child is over 15 and has had a stable prescription for 2+ years, myopia control may offer limited benefit. Discuss the timing with a myopia control specialist before investing thousands of dollars in treatment.
Finding a Myopia Control Specialist
Not every optometrist offers myopia control. Look for providers who list myopia management or pediatric myopia as a specialty area. The American Academy of Optometry (AAO) and the Myopia Institute have provider directories. At the consultation, ask specifically:
- What treatment do you recommend for this child’s progression rate and age?
- What is your target outcome — stopping progression or slowing it?
- How do you monitor effectiveness over time?
- What’s the total first-year cost including all visits and materials?
Annual axial length measurements (measuring the physical length of the eye in millimeters) are the gold standard for monitoring myopia control success — more accurate than refractive change alone. Ask if your provider measures axial length.